Transcatheter aortic valve replacement (TAVR) is a viable alternative to traditional open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery, according to results from the Placement of AoRTic TraNscathetER Valves (PARTNER) II Trial.
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA (prostate-specific antigen) levels who had high-grade cancers, according to a study published today in JAMA Oncology online.
Aclaris Therapeutics, Inc., a clinical stage specialty pharmaceutical company, today announced that it has entered into an agreement with the stockholders of Vixen Pharmaceuticals, Inc. to acquire all of the stock of Vixen.
Researchers from NewYork-Presbyterian/Columbia University Medical Center (CUMC) and University of Miami, with support from the National Institutes of Health and National Institute of Neurological Disorders and Stroke, co-authored a study that may help older people slow their rate of cognitive decline.
Four Columbia Engineering assistant professors have won Faculty Early Career Development (CAREER) awards from the National Science Foundation: Allison Bishop (Computer Science), Matei Ciocarlie, (Mechanical Engineering), Pierre Gentine (Earth and Environmental Engineering), and Nima Mesgarani (Electrical Engineering).